Intravascular Devices

By employing a hypotube and geometrically shaped delivery catheter, stents with differential porosity are accurately positioned in tortuous vascular systems, addressing the challenges of blood flow management and ensuring effective treatment of aneurysms and fistulas.

JP7581255B2Active Publication Date: 2024-11-12ウォルツマンダニエルエズラ
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2021574225
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-05-31
Filing Date
2020-05-31
Publication Date
2024-11-12
Estimated Expiration
2040-05-31

AI Technical Summary

Technical Problem

Current medical devices for treating aneurysms and fistulas in tortuous vascular systems, such as intracranial vessels, face challenges in accurately positioning stents with varying porosity and orientation, leading to potential blood flow obstruction or insufficient flow to branch vessels, and lack effective solutions for treating such conditions in the United States.

Method used

The use of a hypotube as a rail to transport an angioplasty balloon or stent, combined with a delivery catheter having a geometrically non-circular lumen and matching pusher wire, allows for precise orientation and deployment of stents with differential porosity, ensuring optimal blood flow redirection and minimizing distal embolization risks.

Benefits of technology

This method enables accurate placement of stents with varying porosity and orientation, reducing the risk of blood flow obstruction and ensuring adequate blood supply to branch vessels, thereby improving treatment efficacy for aneurysms and fistulas in tortuous vascular systems.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007581255000001
    Figure 0007581255000001
  • Figure 0007581255000002
    Figure 0007581255000002
  • Figure 0007581255000003
    Figure 0007581255000003
Patent Text Reader

Abstract

To provide a method and device for positioning an intracranial occlusion device such as a stent with differential porosity in the correct direction relative to a portion where increased or decreased blood flow is desired (e.g., a branch vessel or an aneurysm, respectively), and the device is particularly used for treating aneurysms in intracranial or other tortuous vessels. [Solution] This problem is solved by an intravascular device and method of use that includes a hub and a delivery catheter with an angled lumen that restrains a pusher wire of a packaging catheter, thereby orienting the stent so that its least porosity is adjacent to the aneurysm and its most porosity is in an orientation that ensures blood flow to branch vessels and other vessels.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] This application is a continuation-in-part of U.S. Patent Application No. 15 / 341,820, entitled "Flow Diversion Covered Stent," filed November 2, 2016 (now U.S. Patent No. 9,775,730, issued October 3, 2017), which claims priority to U.S. Patent Application No. 16 / 214,130, entitled "Caped Stent," filed December 9, 2018, U.S. Patent Application No. 15 / 732,544, filed November 22, 2017, U.S. Provisional Patent Application No. 62 / 921,378, filed December 6, 2019, and U.S. Provisional Patent Application No. 62 / 497,851, filed December 5, 2016, the contents of which are incorporated by reference in their entireties. [Background technology]

[0002] The present invention relates to medical devices used to treat aneurysms and fistulas in unhealthy blood vessels, and more particularly to intravascular devices including diverting, covered, caped, fenestrated, branched and other variable porosity stents for use in tortuous vascular systems such as intracranial stents.

[0003] In the prior art, a number of devices are used to treat aneurysms. One of these is the differentially porous stent, which has an asymmetric braid or coil to allow for the creation of areas of low or high blood flow at will. Fenestrated and branched devices are effective in the aorta, its branches, and other large, less tortuous vessels. The prior art discloses theoretical applications in intracranial and other tortuous and distal vasculature, but does not describe devices or methods for reliably positioning these devices in any radial orientation. The constraints of intracranial and other tortuous vasculature have previously made it difficult to use these devices in these areas.

[0004] The covered stent device disclosed in U.S. Pat. No. 9,775,730 (Walzman) can be safely and efficiently delivered and deployed in tortuous vascular systems and effectively diverts blood flow away from aneurysms, fistulas and ruptured blood vessels while directing blood to healthy tissue distal to the treatment site, preventing congestion and embolization within the aneurysm or fistula.

[0005] U.S. Patent Application Publication No. 2019 / 0151072 (Walzman) discloses a caped stent that includes a cover with overlapping free ends and one attachment point, allowing it to conform to the target vessel better than existing covered stents.

[0006] U.S. Patent No. 8,398,701 (Berez et al.) discloses a vascular occlusion device that can be mounted on a microcatheter. The occlusion device may have an asymmetric braid or lattice of different densities and corresponding / opposite variable porosity to modify blood flow in the vessel away from lesions such as aneurysms while maintaining blood flow to surrounding tissue. Berez states that the flexibility of the device makes it particularly suitable for treating aneurysms in the brain. Berez describes an embodiment that includes lower coverage on one side of the cylinder length than on the other side of the same segment. For example, the area with lower porosity (i.e., higher coverage) should be placed to cover the aneurysm for stagnation and subsequent thrombosis within the aneurysm. The other side of the device with higher porosity should be placed on one side of the vessel or cover the branch to maintain sufficient blood flow and not impede blood flow to the branch or distal tissue. However, Berez et al. do not consider how to stably and reliably position such an instrument in any optimal radial orientation, and no such instrument exists.

[0007] Taken to an extreme, an intravascular device may be fenestrated to increase porosity and provide complete unimpeded blood flow at the bifurcation of the branch vessels, which in an extreme case may be combined with a full covering on or near the opposing flank to completely block blood flow to the targeted aneurysm or fistula.

[0008] A common vascular difficulty is the persistence of blood flow within the aneurysmal sac external to the endograft. In fact, this is the most common complication after endovascular aneurysm repair (EVAR) using stent grafts. Such endoleaks can be ameliorated in a variety of ways. For example, U.S. Patent Applications 15 / 732,147 and 15 / 732,365 to Walzman show the use of hydrogels to prevent endoleaks.

[0009] The prior art has introduced endovascular coiling as a minimally invasive technique to prevent blood from flowing into some saccular aneurysms. With this treatment, the coils induce embolization (clotting) of the aneurysm, preventing blood from flowing into the aneurysm, thereby preventing rupture and subsequent subarachnoid hemorrhage. However, endovascular coiling may lead to postoperative complications such as thromboembolism, cerebral embolism, aneurysm perforation, parent artery occlusion, coil migration, and arterial dissection. The prior art also discloses stent-assisted coiling, which suffers from the same drawbacks associated with stent placement, and requires the long-term use of antiplatelet drugs to reduce the risk of stenosis due to thrombus in the stent before stenting the parent artery.

[0010] Some aneurysms and fistulas are ideally suited for treatment with covered stents. Covered stents can most directly cover the fistula hole or aneurysm neck to reconstruct the vessel wall and immediately redirect blood flow to the normal path of the parent vessel. However, there are currently no covered neurostents available in the United States. The U.S. Food and Drug Administration (FDA) has tested and inspected such covered neurostents, but none have been "FDA approved," meaning that the FDA has determined that the benefits over existing treatment options do not outweigh the potential risks when the device is used. Additionally, no covered stents are currently available for use in highly tortuous tissues in other parts of the body, such as splenic artery aneurysms or pulmonary arteriovenous fistulas.

[0011] An important potential application of covered neurostents may be in the treatment of fistulas, particularly carotid-cavernous fistulas (CCFs), which are abnormal connections between the cavernous sinus and the carotid artery system.

[0012] Alternative treatments for aneurysms include surgical clipping of intracranial aneurysms, which involves placing a clip around the neck of the aneurysm. This treatment has drawbacks, including the need for open surgery and physical manipulation of the brain. Surgical bypass surgery is sometimes considered, but is generally associated with higher morbidity and mortality.

[0013] Additionally, the prior art discloses the use of flow diverter devices to divert blood flow away from an aneurysm by placing a mesh-like stent or stent-like structure along the parent artery at the neck of the aneurysm. These devices can be used to form a thrombus inside the aneurysm. However, placement of the flow diverter devices can result in increased technical complications.

[0014] Additionally, they are generally ineffective in treating fistulas or vascular ruptures because they do not completely occlude blood flow. Similarly, there is currently no effective vessel-sparing therapy for iatrogenic rupture of intracranial arteries. Current treatments typically require occlusion of the ruptured artery with coils or liquid embolic agents to stop bleeding, which is usually accompanied by significant morbidity due to ischemic injury to the arterial territory. Furthermore, when aneurysms are treated with these devices, the aneurysm becomes thrombosed over time (lag period) and does not heal immediately. This puts the patient at risk of aneurysm rupture during the lag period. This is particularly problematic when treating aneurysms that have a high re-rupture rate during the short term. Furthermore, with current flow-diverting stents, multiple branch vessels may cross the device, resulting in stenosis or sometimes occlusion or injury at the bifurcation of these branch vessels.

[0015] There is a need for an intravascular device capable of vascular intervention for immediate healing of selected endovascular aneurysms and fistulas, but the difficulties and shortcomings of the current technology must be overcome. More specifically, there is a need for a covered stent that can move freely and bend without kinking, even around tight turns in tortuous tissue.

[0016] Most covered stents are constructed by constructing a cylinder of the stent's "skeleton" or "frame" out of a semi-rigid material such as an alloy, to which is attached an impermeable "cover." In the prior art, such attachments were distributed over the entire stent cover at intervals on the cover and frame, resulting in a significant limitation of the flexibility of the device.

[0017] All current flow-diverter stents have a relatively uniform overall coverage and porosity pattern, but no reliable means have been developed for successfully deploying devices with circumferentially varying porosity.

[0018] No known device or method allows precise positioning of such differential porosity devices in neurovascular procedures (and other tortuous tissues) to achieve ideal ratios of coverage and porosity at any location and direct blood flow to the desired location. Unlike large blood vessels (e.g., the aorta), devices inserted into the intracranial or other tortuous circulatory systems have little effect on rotating the cranial end by manually rotating the hub end.

[0019] Therefore, there is a need for an instrument that can be reproducibly positioned / reached in the proper orientation so that an area of ​​dense coverage and correspondingly low porosity (in the extreme case, completely impermeable) is placed on any side, while a less dense coverage and correspondingly high porosity (and / or in the extreme case, fenestrations without any coverage at all) is placed on any side. Also, for distal tortuous vessels, a branched covered flow diverting instrument is needed. Currently, such instruments cannot be used for neurovascular procedures, and similarly for other tortuous vasculature, because no devices, systems, or methods exist to reliably and accurately place such instruments in any orientation.

[0020] Thus, when such a device is deployed, its final orientation upon deployment will be random. For example, in the previous case, the opposite of what is ideal may occur: the fenestration may end up overlying the aneurysm, increasing blood flow to the lesion, while the dense coating may end up overlying the branching point of a healthy branch vessel, resulting in insufficient blood flow to that branching point and subsequent ischemic injury.

[0021] Also, using the extreme example of a fenestrated device of the present invention, a branched device can be constructed in vivo by placing a fenestrated device with its fenestration overlapping the bifurcation point of a branch and then placing another device through the fenestration into the branch. The second device can be slightly larger in proximal diameter so that it slightly overlaps the fenestration without covering the first distal branch / vessel. Similarly, a device can be constructed that includes multiple branches through multiple fenestrations, provided that all fenestrations are at the appropriate relative distance and orientation to the actual branch.

[0022] This concept has been clearly described by Ruiz in U.S. Patent No. 6,261,273, "Access System for Branched Vessels (and) Method of Use." However, Ruiz describes how to make a directional sheath and catheter in vivo, but not how to implant it. Unfortunately, the Ruiz device, like the Berez device, is easily adapted to function in tissues with short linear anatomy where the catheter can be easily and precisely rotated from its proximal hub over its entire length.

[0023] Rotation is ineffective at positioning in tortuous and / or long vasculature where the catheter does not respond as expected. This generally creates difficulties when a crimped stent device for delivery is advanced through a delivery catheter in a particular configuration, typically using a delivery wire and / or hypotube. The stent emerges from the delivery catheter in an unpredictable configuration and orientation.

[0024] Additionally, it has not been practical to place or assemble Y-shaped branching stents in the branches of the skull or other tortuous vasculature. These stents have a relatively low porosity, which can be difficult to cross and adversely affect blood flow to the branching vessel. Additionally, such devices are not large enough to cross with additional wires, microcatheters, and / or stents. There is a need for Y-shaped, branched, and other branched stent devices that can be effectively placed or assembled in tissues of such structures. Additionally, new devices and methods are needed to more precisely deliver the proximal end of such stent devices to safely and precisely deploy such branches and closely and reliably overlap the fenestrations.

[0025] Thus, there is a need for a covered or partially covered neurostent that can be used in tortuous intracranial and extracranial tissues and that allows for targeted placement of high and low porosity regions of the device relative to one or more branch vessels and at least one aneurysm or fistula, respectively. There is also a need for a similar covered or partially covered branch device. The present invention fulfills these unmet needs. Summary of the Invention [Problem to be solved by the invention]

[0026] The present invention discloses an embodiment in which a hypotube, rather than a solid wire, crosses the stenosis and is used as a rail to carry an angioplasty balloon or stent. Such a hypotube can be fluid-passed through it, thus reducing the cerebral sump effect from flow reversal while still maintaining sufficient retrograde flow to overcome any flow from the external carotid artery and to maintain retrograde flow across the lesion during angioplasty and stent placement, thereby minimizing the risk of distal intracranial embolism.

[0027] The present invention also relates to methods and apparatus for properly orienting intracranial occlusion devices, such as differential porosity stents, to areas where increased or decreased blood flow is desired (e.g., for branch vessels and aneurysms, respectively). The present invention is particularly well suited for use in the treatment of aneurysms and fistulas, as well as vascular stenosis and other pathologies in the intracranial and other tortuous vasculature.

[0028] Achieving such a desired orientation is difficult due to several factors. The lumen of the delivery catheter, from which the stent may be deployed, is typically circular. The stent itself usually rotates unpredictably within said lumen during placement. Also, the catheter itself may twist and rotate unpredictably as it navigates through tortuous tissue. Thus, placement of the device in the desired radial orientation is a matter of chance, with sometimes negative results opposite to those expected. The following devices and procedures are disclosed to overcome this difficulty.

[0029] Differential porosity stents or other such braided, mesh or woven therapeutic devices can be oriented to suit the desired degree of flow or obstruction.

[0030] The stent is equipped with an optional free-floating cover whose design is optimized for insertion into tortuous tissue. Among its unique structural elements are a single circumferential attachment point (as small as 1 nm) at one end, overlapping circumferential plates, and overlapping geometric plates.

[0031] The disclosed devices may be placed under hemostasis, either by pharmacological means or by delivery through a balloon guide catheter with a temporarily inflated balloon, or by other means, while still in the unsheathed state to minimize the possibility that blood flow may affect positioning.

[0032] In yet other embodiments, the covering may not completely surround a portion of the frame, such that a stent may have a covered portion along its circumference and an uncovered portion on a different circumferential side of the site, which may preserve the branching point of a branch vessel on the opposite side of a fistula or aneurysmal radius, for example a branch vessel that branches off from the same portion of a parent vessel.

[0033] The present invention further discloses an apparatus and method for more accurately positioning the proximal end of a stent, so that when the fenestration of a first stent is positioned at the bifurcation, a second stent can be precisely positioned so that its proximal end slightly overlaps the periphery of the fenestration of the first stent, thereby preventing leakage between the two stents and preventing unwanted occlusion of the main vessel by the proximal end of the second stent.

[0034] More precise "positioning" of the proximal end of the stent can be achieved by the unique devices and methods described herein. An inner "unsheathed" hypotube or wire is described herein, which has inverted cone-shaped "wings" at its distal end that are folded over the stent. The stent can be attached to the distal end of the outer hypotube. The inner hypotube or wire passes inside the outer hypotube, and its wings extend to fold over the distal end of the outer hypotube and the stent attached thereto, constraining the stent. The stent is typically a self-expanding stent. Once the stent is in the desired location, the outer hypotube is held in place and the inner hypotube or wire is advanced. As the inner hypotube or wire advances, its wings also advance, unconstraining the stent from proximal to distal. This allows the proximal stent to be released first and deployed for deployment. If proximal deployment is not optimal, it can be resheathed by again pulling back the inner hypotube, which allows the stent to be repositioned and deployment to be resumed.

[0035] In an embodiment of the invention, a hypotube, rather than a solid wire, crosses the stenosis and serves as a rail to carry angioplasty balloons and stents. Such a hypotube also allows fluid to pass through it. This reduces the sump effect of backflow on the brain while still maintaining sufficient backflow to overcome any flow from the external carotid artery and to maintain backflow across the lesion during angioplasty and stent placement. This minimizes the risk of distal intracranial embolism.

[0036] In some embodiments, irrigation is possible via the angioplasty balloon and / or its delivery catheter. Furthermore, in some embodiments, an angioplasty balloon catheter and / or an additional balloon attached to a wire or hypotube, or a separate balloon, is used to distally occlude the carotid artery at each stage of the surgery to prevent distal embolization while minimizing sumping of blood flow from the brain. This allows for a short period of time during and after balloon deflation during which retrograde flow is applied.

[0037] Additionally, in some embodiments, a series of angioplasty balloons and / or stents, and their delivery catheters, are delivered sequentially one above the other, thereby minimizing the number of device exchanges required, shortening procedure times and reducing the risks associated with device exchanges.

[0038] The present invention also discloses the bifurcated stent embodiment described above.

[0039] An additional embodiment includes a Y-shaped stent, where a first stent has an increased porosity and a larger hole over the bifurcation of a branch vessel, and a second stent passes through the larger hole over the bifurcation of the branch vessel and has increased porosity where it crosses the main vessel in which the primary stent was placed. [Brief description of the drawings]

[0040] [Figure 1] FIG. 1A is a perspective view of a cylindrically shaped delivery catheter 330 having a triangular lumen 1 showing the cross-sectional shape of the catheter lumen.

[0041] FIG. 1B shows an embodiment of a cylindrical, sheathless (not shown) delivery catheter lumen 3 having a proximal end 1 and a distal end 2, passing through a blood vessel 1000 such that a hole 2 at the distal end is positioned near a target aneurysm 2000.

[0042] 1C is a cross-sectional view of the delivery catheter lumen 3. The delivery catheter lumen 3 has a triangular lumen with an angle ABC. The pusher wire 300 is inserted through this lumen with its corner offset to CAB. This is to deliver an occlusion device (not shown) with a difference in porosity in an orientation rotated 120° so that it can be positioned at the desired rotation angle.

[0043] [Diagram 2] FIG. 2 shows the proximal and distal ends 10 and 20 of the stent packaging catheter 30 (outside the patient's body), a hub 700 attached to a delivery catheter lumen 3, a hub port 701 of the packaging catheter showing a pusher wire 300 inserted therein, and further shows the pusher wire 300 (dashed line running along and through the delivery catheter lumen 3) with its distal end 303 removably attached to a stent 301 near the target aneurysm 2000, the distal end 20 of the stent packaging catheter 30 positioned within the hub port 701, the delivery catheter lumen 3 (oriented with a triangular hole 1 at the proximal end and a triangular hole 2 at the distal end near the target aneurysm 2000), and the delivery catheter lumen 3 positioned within the vascular wall 1000.

[0044] [Diagram 3]FIG. 3 shows a pusher wire 300 and a stent 301 disposed at a distal end 303 of the pusher wire within a vessel wall 1000 after the delivery catheter lumen 3 (see FIG. 2) has been removed.

[0045] [Figure 4] 4 is an internal view of a triangular delivery catheter lumen 3. The inside of the delivery catheter lumen 3 is defined by proximal sides 4, 5, and 6 which correspond to distal side 44 (the hypotenuse distal sides 55 and 66 behind 44 are shown in FIG. 5). Surface 444 indicates the entire length of the catheter side starting at proximal side 4 and ending at distal side 44. In other embodiments (not shown), other regular shapes such as rectangles or stars may be used.

[0046] [Diagram 5] 5 shows the inner proximal surface 555 of the delivery catheter of FIG. 4 (or FIG. 4 rotated 120 degrees). Surface 555 starts at proximal side 5 and ends at distal side 55 (with distal sides 44 and 66 of the hypotenuse behind 55 shown in dashed lines). Surface 555 further includes a radiopaque orientation aid marker 5550.

[0047] [Figure 6] 6 shows a stent 301 attached at its proximal end to the distal end 303 of a pusher wire 300. The stent 301 has a triangular shape with a distal end 3010 and the sides of the triangle at the end face 303, i.e. sides 334, 355, and 366. The distal end 3010 of the stent 301 shows triangular side 3550, with dotted lines showing the other two sides 3440 and 3660 of the triangle. Triangular side 355 defines a plane whose length terminates at side 3550. A radiopaque marker 55500 is provided on the plane.

[0048] [Figure 7] 7A and 7B show the configuration of the delivery catheter lumen 3 with the radiopaque markers in relative position.

[0049] [Figure 8] FIG. 8 shows one possible configuration of the pusher wire.

[0050] [Figure 9] FIG. 9 shows a packaging catheter.

[0051] [Figure 10] FIG. 10 shows another option for a packaging catheter.

[0052] [Figure 11] - [Figure 12] 11 and 12 show the relative positions of the radiopaque markers.

[0053] [Figure 13] - [Figure 14] 13 and 14 show another embodiment of a reverse unsheathed stent. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0054] An embodiment of the device of the present invention and its modified examples will be described with reference to the above drawings.

[0055] 1A shows a perspective view of a cylindrical delivery catheter 330 having a triangular lumen 1. The present invention discloses cylindrical delivery catheters having a straight lumen, such as a triangular, square, other rectangular, star, hexagonal, etc. shape, that is designed to support a pusher wire of the same shape that is configured to be inserted at different fixed angles relative to lumen 1.

[0056] 1B shows an embodiment of a delivery catheter lumen 3 excluding a cylindrically shaped sheath (not shown). The delivery catheter lumen 3 has a proximal end 1 and a distal end 2, and passes through a blood vessel 1000 such that a hole 2 at the distal end is located near a target aneurysm 2000. The delivery catheter lumen 3 is inserted into the blood vessel 1000 until the distal end 2 stops close to the target aneurysm 2000. Due to the straight configuration of the lumen 1, the delivery catheter lumen 3 has a set orientation with respect to having one side closest to the target aneurysm 2000.

[0057] FIG. 1C shows a cross-sectional view of a delivery catheter lumen 3 with a triangular lumen with an angle ABC. A pusher wire 300 is inserted therein at an offset angle such that the angle is CAB. This is to deliver a differential porosity occlusion device (not shown) at an angle of 120° to place it at the desired rotation angle. The present invention teaches that the orientation of the pusher wire can be fixed outside the patient's body by fixing the relative orientation of the pusher wire with respect to the delivery catheter lumen 3. By establishing the orientation of the delivery catheter lumen 3 with respect to the target aneurysm 2000 prior to insertion of the pusher wire 300, the practitioner of the device of the present invention can insert the pusher wire 300 in the proper orientation with respect to the aneurysm 2000 without rotating the pusher wire 300 inside the patient's body. The present invention includes the basic concept of having a geometrically non-circular lumen and a matching pusher wire or hypotube. This allows the user to prevent unwanted rotation of the device within the delivery catheter or blood vessel. The present invention also allows for predictable radial orientation delivery by utilizing markers on the hub and corresponding radial markers on the tip of the delivery catheter. After placement of the delivery catheter in intracranial or similar tortuous tissue, the tip can be imaged to determine the degree of twisting relative to the hub marker and the target lesion. The stent device is then inserted in the appropriate orientation relative to the hub marker so that it is delivered in the desired orientation into the target vessel. For example, if the hub marker is at 12 o'clock and the tip marker is at 4 o'clock, the device / stent can be inserted knowing that no matter what porosity is inserted at the 12 o'clock position on the hub, it will be consistently delivered to the 4 o'clock position at the catheter tip. Similarly, stent devices can be preloaded into packaging catheters of similar geometry and having a 12 o'clock marker (or similar marker) at various deployment angles relative to the 12 o'clock circumferential position. Depending on the desired orientation, the appropriate preloaded device can then be selected and utilized.Alternatively, the devices can be preloaded in the same orientation and the packaging catheter can be rotated at various angles relative to the delivery catheter and its hub to provide the desired orientation for the stent device when it is transferred from the packaging catheter to the delivery catheter. As is well known in the art, the packaging catheter is typically shorter than the delivery wire or delivery hypotube. The stent is preloaded on the delivery wire or hypotube within the packaging catheter. The transfer of the stent device is accomplished by connecting the packaging catheter and the delivery catheter within the hub of the delivery catheter and pushing / pushing the rear of the wire / hypotube that extends from the rear of the packaging catheter. The wire / hypotube is pushed with the stent attached thereto, usually until most of the pusher wire / hypotube is in, or at least until the stent is completely in the delivery catheter. The packaging catheter is removed from the remaining portion of the hypotube / wire, and the operator continues to push the hypotube / wire until the stent reaches the end of the delivery catheter. The stent is then deployed by pushing the stent out or by retracting the delivery catheter to unsheath the stent, or a combination thereof. Also, in a preferred embodiment, the pusher wire / hypotube, packaging catheter, and delivery catheter have corresponding geometries and similar internal dimensions for the packaging catheter and delivery catheter (excluding the hub). The wire / hypotube is mated to them in a lock-in-key manner so that it fits snugly and slides within them. This allows the wire / hypotube to advance within the catheter without rotating. For example, in one embodiment, the pusher wire / hypotube has a triangular cross-sectional profile that fits into the triangular lumen of the packaging catheter and delivery catheter.

[0058] Reference is now made to Figure 2, which shows the proximal and distal ends 10 and 20 of the stent packaging catheter 30 (outside the patient's body), the hub 700 attached to the delivery catheter lumen 3, the hub port 701 of the packaging catheter showing the pusher wire 300 threaded therethrough, and further shows the pusher wire 300 (dashed line running along and through the delivery catheter lumen 3) with its distal end 303 removably attached to the stent 301 proximal to the aneurysm 2000 of interest, the distal end 20 of the stent packaging catheter 30 disposed within the hub port 701, the delivery catheter lumen 3 (oriented with triangular hole 1 at the proximal end and triangular hole 2 at the distal end proximal to the aneurysm 2000 of interest), and the delivery catheter lumen 3 positioned within the vessel wall 1000.

[0059] The packaging catheter 30 is connected to a port 701 of the hub 700. At this time, the packaging catheter 30 is connected so that the stent 301 and the pusher wire 300 are arranged in a desired orientation, that is, so that the surface of the stent 301 with the least porosity is sufficiently oriented toward the target aneurysm 2000.

[0060] Now, please refer to FIG. 3. In FIG. 3, the pusher wire 300 and the stent 301 are shown in the vessel wall 1000 after the delivery catheter lumen 3 (see FIG. 2) has been removed, and the pusher wire 303 is located distal to the pusher wire 303. When the stent 301 is located adjacent to the aneurysm 2000, the stent 301 is activated and deployed so that its non-porous side contacts the aneurysm 2000. Meanwhile, the other two sides of the triangular stent 301 are porous to promote blood flow. The present invention also discloses a "12 o'clock" marker on the hub and a radiopaque "12" marker on the distal end of the catheter.

[0061] Reference is now made to Figure 4, which is an internal view of a triangular delivery catheter lumen 3. The inside of the delivery catheter lumen 3 is defined by proximal sides 4, 5, and 6 which correspond to distal side 44 (the hypotenuse distal sides 55 and 66 behind 44 are shown in Figure 5). Surface 444 indicates the entire length of the catheter side starting at proximal side 4 and ending at distal side 44.

[0062] The luminal orientation of the delivery catheter lumen 3 should be clearly discernible. Figure 4 shows a triangular shape with sides 4, 5, and 6 at its proximal end and side 44 at its distal end on side 444. In other embodiments (not shown), other regular shapes such as a rectangle or a star may be employed.

[0063] Reference is now made to FIG. 5, which shows the inner proximal surface 555 of the delivery catheter of FIG. 4 (or FIG. 4 rotated 120°). The proximal surface 555 starts at the proximal side 5 and ends at the distal side 55 (the hypotenuse distal sides 44 and 66 behind 55 are shown in dashed lines). The proximal surface 555 further includes a radiopaque orientation aid marker 5550. FIG. 5 is a rotated image of FIG. 4, showing the proximal surface 555 terminating at the proximal side 5 and the distal side 55. The radiopaque marker 5550 on the proximal surface 555 allows the user to determine the relative orientation of one side of the delivery catheter lumen 3. Based on this information, the packaging catheter 30 is properly oriented with respect to the hub port 701 so that the pusher wire 300 and the stent 301 are properly aligned or oriented when they are in the vicinity of the aneurysm 2000.

[0064] Reference is now made to Figure 6, which shows a stent 301 attached to a distal end 303 of a pusher wire 300, and a proximal end of the stent 301. The stent 301 is triangular in shape with sides of the triangle on the plane of the distal end 3010 and the proximal end 303, specifically sides 334, 355, and 366. The distal end 3010 of the stent 301 shows triangular side 3550, with dotted lines showing the other two sides of the triangle 3440 and 3660. Triangular side 355 defines a plane whose length terminates at side 3550. A radiopaque marker 55500 is provided on that plane.

[0065] (First Method) A delivery catheter is used that has a "12 o'clock" marker on the proximal hub of the catheter. The 12 o'clock marker may be located on the hub and on the tip of the delivery catheter (e.g., a radiopaque marker on the catheter tip). The user inserts a stent packaging catheter therein that has a differential porosity stent or occlusion device attached to a pusher wire. After testing, the user rotates the packaging catheter to the desired graduation in the hub.

[0066] Although the scale may be displayed anywhere on the hub to point in any direction on the hub, calling it the 12 o'clock scale or 12 o'clock marker is convenient to explain its location relative to the marker to those familiar with analog clock faces. For example, asking the user to rotate the hub to "3 o'clock", "6 o'clock", and "9 o'clock" intuitively evokes 1 / 4, 1 / 2, and 3 / 4 rotations, respectively, with the other "hours" representing approximate locations between these 90° references (e.g., 2 o'clock, 5 o'clock, 11 o'clock). A similar effect can be achieved by using terms such as east, south, and west (or intermediate positions such as east-southeast or north-west) relative to the "north" marker, with "12 o'clock" being the preferred reference. The important thing is not the terminology, but the ability to manually rotate the orientation relative to the delivery catheter through a 360° range.

[0067] Using a packaging catheter with a distal marker, a test stent, or final stent, is advanced in a specific orientation relative to the 12 o'clock marker on the delivery catheter. The stent (or other marked intravascular device) will usually end up in roughly the same, but unpredictable, orientation. This process may be repeated to ensure that the markers on the delivery catheter and packaging catheter are consistently aligned. The marker on the test stent / device is then imaged relative to the marker on the tip of the delivery catheter, and a determination is made as to which orientation (e.g., what "hour" on the "clock") the stent should be loaded onto the delivery catheter to achieve the desired orientation. Alternatively, a stent may be used that is preloaded into the delivery catheter in the desired orientation relative to the "12 o'clock" marker.

[0068] If necessary, an additional test stent / device may be temporarily inserted in the expected orientation and imaged to confirm orientation before removing the test device and inserting and deploying the permanent device.

[0069] For example, if testing indicates that the fenestration is positioned in a "7 o'clock" orientation, which is offset 90 degrees clockwise relative to the target branch vessel, the stent packaging catheter is then repositioned to a "4 o'clock" orientation so that the fenestration is properly oriented adjacent the target branch vessel.

[0070] Once the catheter tip orientation has been imaged, the loaded stent is deployed in the proper orientation relative to the similarly placed hub marker. Again, if necessary, a "test" device / stent with added radiopaque markers can be retrievably placed to confirm orientation.

[0071] (Second Method) A second method is disclosed that utilizes the steps and markers of the first method described above, and further utilizes a delivery catheter having a lumen of a unique cross-sectional geometry formed therethrough. In a typical embodiment, the exterior surface of the delivery catheter is conventionally cylindrical and sufficiently rounded to facilitate navigation through the vascular circulation. A non-rounded lumen minimizes rotation and increases predictability of orientation during placement of the stent packaging catheter and wire.

[0072] The accompanying drawings show a triangular lumen as an example, however, other shapes such as a square, hexagon, octagon, pentagon, a "house" silhouette, a star, etc. may be used instead, the star may be any shape, such as a six-pointed "Star of David" or other geometric shape, but one shape is used throughout the lumen.

[0073] In a further embodiment, the packaging catheter may be shaped to correspond to the shape of the lumen of the delivery catheter. This correspondence is shown, for example, in accompanying Figures 1A and 1B. In this embodiment, the packaging catheter and the delivery wire / hypotube have a form-fitting shape that prevents them from rotating relative to one another, but allow for some clearance to move back and forth relative to one another. In this embodiment, the orientation of the delivery catheter and the stent / device inserted therethrough are maintained in the same orientation, thereby providing a predictable and accurate desired and proper orientation.

[0074] Again, a "12 o'clock" marker can be placed on the hub and catheter tip to indicate the same orientation (the catheter tip marker is radiopaque). The catheter tip orientation can then be imaged and a stent mounted with the appropriate orientation relative to the similarly placed hub marker can be used. Again, if necessary, a "test" device / stent with an additional radiopaque marker can be retrievably placed to confirm orientation. Once the catheter has been delivered into intracranial or similar tortuous tissue and its tip marker orientation has been satisfactorily imaged, the tip marker orientation and its rotational offset from the hub marker can be used to determine the angle of deployment without the need for any retrievable test stent device.

[0075] (Common Method) Using any of the above described instruments and methods, a fenestration can be precisely placed at the bifurcation of a branched vessel. A wire is then advanced through the fenestration into the branched vessel and either: (a) A balloon expandable device / stent is carried over the wire and positioned so that its proximal end minimally overlaps the fenestration of the original stent / device, and if desired, the branch section may be tapered slightly larger at the fenestration side relative to the portion that extends into the branch vessel. (b) A second delivery catheter (or the first delivery catheter may be reused) is delivered to the branch vessel (the wire may be optionally removed) and an additional branch stent, typically self-expanding, is delivered through the delivery catheter, again, the branch section may be tapered slightly larger on the fenestrated side relative to the portion that extends into the branch vessel.

[0076] Delivery method (b), however, makes it difficult to accurately place the proximal stent, especially since "woven" or "braided" stents foreshorten significantly and unpredictably (compared to their length when crimped onto the delivery catheter) upon placement.

[0077] Another option is a new delivery device for such stents. In this embodiment, it is mounted on a device / catheter similar to the "winged inner catheter" of a filter-tip TAVR (transcatheter aortic valve replacement) catheter. In other words, a "central tube" and a "retaining structure connected to the distal end of the central tube and extending from the distal end of the central tube toward the proximal end" as described in the Walzman patent (US Pat. No. 1,030,724,262). The "wings" fix the correct orientation while being guided through the angulated lumen 1 of the delivery catheter. The stent has one or more external wires attached, ideally attached to the proximal and distal ends of the stent in the preferred embodiment (this can be "over the wire" but is more preferably "rapid exchange"), and once the first stent is deployed with its fenestration over the bifurcation of the branch vessel, a second wire is passed through the fenestration into the branch vessel and the second stent / device is advanced along the wire to the desired location. A second stent / device is delivered constrained by the retention structure described above and has at least one second wire attached to the outside of the central tube of the stent or an outer tube attached to the stent. The wire (or alternatively, an outer catheter) with the stent attached is held in place while the "winged inner catheter" is advanced to expose / unsheath the stent from the proximal end.

[0078] The present invention also discloses an unsheathing device for bifurcated stents. More specifically, the present invention discloses a proximal first unsheathing device. In the above example, if the stent is attached by a wire, the wire can expand the stent. If the stent is attached to an outer catheter (which is outside the inner catheter but inside the stent; the wings are outside the stent), it is necessary to wait for the entire stent to be unsheathed before cutting off the proximal end of the stent. Alternatively, if the proximal circumference of the stent is attached to the outer catheter and furthermore the distal portion of the stent has at least one additional wire attached or has additional attachments to the distal portion of the stent on the outer catheter, the proximal side can be cut off when the proximal portion of the stent is unsheathed, ensuring the proper orientation and position of the fenestrations with slight overlap, but without significant coverage of the main vessel, and the distal side of the stent can be cut off after the entire stent is deployed.

[0079] The stent is suitably mounted only distally to the "outer catheter". To advance the system, the outer catheter is pushed to pull on the stent attached to it, and the wings of the inner catheter are pushed (which pushes the entire inner catheter as one unit). Once the stent is in the proper position, the second stent can be unsheathed by advancing the inner catheter while holding the outer catheter (and its attached stent) in place. This is done by first unsheathing the proximal side of the stent with a self-expanding stent; the proximal side of the stent automatically deploys as it is unsheathed. If it becomes misaligned, the inner catheter can be pulled back to resheath the proximal side of the stent, which can then be repositioned before being unsheathed again.

[0080] Additionally, when "braided" or "woven" stents are used, as these take longer and are less predictable to fully deploy, a Nitinol wire ring may be provided at the proximal end of the stent (and optionally elsewhere) to facilitate more rapid deployment / self-expansion of the stent's maximum diameter, and similar longitudinal wires may be attached to allow smooth resheathing, if desired. Multiple rings may be added at intervals along the stent device.

[0081] A preferred method is more particularly described through the following steps, which utilize an embodiment of the device in which the pusher wire shape is congruent with the angular shaped lumen of the delivery catheter (e.g., a triangular pusher wire and a triangular lumen). (a) inserting a delivery catheter into the body; (b) pushing the proximal end of the delivery catheter along the delivery wire until the distal end of the delivery catheter is proximate to the target aneurysm; (c) Remove the delivery wire. (d) imaging the placement angle of the distal radial marker relative to the target aneurysm; (e) orienting the packaging catheter relative to the 12 o'clock marker of the hub to optimize the angle of stent deployment relative to the target aneurysm; (f) inserting the packaging catheter into the hub; (g) pushing the pusher wire so that the stent is completely inserted into the delivery catheter; (h) removing the packaging catheter; (i) pushing the pusher wire until the stent is proximate to the target aneurysm; (j) developing a main portion of an obturator having a differential porosity; (k) Repeat imaging to confirm that the instrument orientation is as expected; (l) Fully deploy the remainder of the differential porosity obturator; (m) Withdraw the pusher wire and delivery catheter.

[0082] (Bifurcation or V-shaped stent) Using the procedure described above, a "Y" stent can be assembled in vivo from the two stents using the markers as a reference.

[0083] The present invention may employ self-expanding components.

[0084] The present invention may employ a balloon expansion member.

[0085] The present invention may optionally include radiopaque components and / or radiopaque markers, which are particularly useful for identifying the ends of the stent and the ends and edges of the coverage area. Radiopaque material and markers may be provided in many more locations, sometimes throughout.

[0086] The present invention may have bifurcated stent elements.

[0087] The stent element of the present invention may be entirely resheathable.

[0088] The stent elements of the present invention may be partially resheathable.

[0089] All stent elements of the present invention may be removable.

[0090] It will be appreciated by those skilled in the art that the above embodiments are described by way of example only. The principles and features disclosed herein may be employed in a variety of different and numerous embodiments without departing from the scope and spirit of the present disclosure as claimed. The above-described embodiments are illustrative of the scope of the present disclosure, but are not intended to limit the scope of the present disclosure.

Claims

1. 1. An intravascular device comprising: (a) a delivery catheter having a proximal end, a distal end, and an angled lumen, the delivery catheter being operable to: (i) Navigating intravascularly toward a target aneurysm (ii) stopping in the vicinity of the aneurysm. (iii) withdrawing the blood vessel. (b) a packaging catheter; (c) a pusher wire having a proximal end and a distal end; a differentially porous occlusion device removably mounted on the distal end of the pusher wire, (d) a hub attached to the delivery catheter and having a packaging catheter port; With respect to the delivery catheter, the packaging catheter, and the pusher wire, directions around their axes are referred to as rotation directions, and arrangement angles of the delivery catheter, the packaging catheter, and the pusher wire in the rotation directions are referred to as rotation angles, and the packaging catheter port is capable of receiving the distal end of the pusher wire at at least two types of rotation angles; (e) the pusher wire is capable of sliding the occlusion device through the angled lumen; the pusher wire maintains the rotational angle relative to the delivery catheter while the distal end of the pusher wire travels through the blood vessel to the aneurysm; (f) the packaging catheter is further capable of rotating the distal end of the pusher wire leading to the delivery catheter so as to position the occlusion device in a desired orientation. Intravascular devices.

2. the occlusion device is a stent; 2. The intravascular device of claim 1, wherein the more porous portion of the stent can be positioned at a desired location within a blood vessel by adjusting the rotation angle of the packaging catheter.

3. 3. The intravascular device of claim 1 or 2, wherein the hub is provided with a "12 o'clock" marker.

4. 4. The intravascular device of claim 1, wherein the delivery catheter has a radiopaque marker at its distal end.

5. 5. The intravascular device of claim 1, further comprising a radiopaque marker at a distal end of the pusher wire.

6. 6. The intravascular device of claim 1, wherein the pusher wire has an angular cross-sectional shape congruent with the lumen of the delivery catheter.

7. 7. The intravascular device of claim 1, wherein the pusher wire is shaped to closely match the internal shape of the lumen of the delivery catheter so as to advance within the delivery catheter without rotation.

8. the occlusion device has a non-porous surface; 8. An intravascular device according to any one of claims 1 to 7, characterized in that the non-porous surface can be positioned in a desired orientation within a blood vessel by adjusting the rotation angle of the packaging catheter.

9. 9. The intravascular device of claim 1, wherein the delivery catheter is cylindrical.

10. 10. The intravascular device of any one of claims 1 to 9, wherein the angular shaped lumen is triangular or rectangular.

11. 11. The intravascular device of any one of claims 1 to 10, wherein the packaging catheter has a shape that is the same as the angular lumen of the delivery catheter.

12. 1. An intravascular device comprising: (a) a delivery catheter having a proximal end, a distal end, and an angled lumen, the delivery catheter being operable to: (i) Navigating intravascularly toward a target aneurysm (ii) stopping in the vicinity of the aneurysm. (iii) withdrawing the blood vessel. (b) a packaging catheter; (c) a pusher hypotube having a proximal end and a distal end; a differentially porous occlusion device removably mounted on the distal end of the pusher hypotube, (d) a hub attached to the delivery catheter and having a packaging catheter port; Regarding the delivery catheter, the packaging catheter, and the pusher hypotube, the directions around their axes are referred to as rotation directions, and the arrangement angles of the delivery catheter, the packaging catheter, and the pusher hypotube in the rotation directions are referred to as rotation angles. The packaging catheter port is capable of receiving the distal end of the pusher hypotube at at least two types of rotation angles, (e) the pusher hypotube is operable to slide the occlusion device through the angled lumen; the pusher hypotube maintains the rotational angle relative to the delivery catheter while a distal end of the pusher hypotube travels through the blood vessel to the aneurysm; (f) the packaging catheter is further capable of rotating the distal end of the pusher hypotube for delivery to the delivery catheter so as to position the occlusion device in a desired orientation. Intravascular devices.

Citation Information

Patent Citations

  • Stent delivery catheter positioning device

    JP2005506100A

  • flexible vascular closure device

    JP2008502378A

  • Method for deploying a double concentric guidewire and branched graft.

    JP2010515553A

  • Medical devices and related systems and methods

    US20080015674A1